{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:49:44Z","timestamp":1777438184492,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870660"],"award-info":[{"award-number":["81870660"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Foundation","doi-asserted-by":"crossref","award":["18ZR1405900"],"award-info":[{"award-number":["18ZR1405900"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12016116"],"award-info":[{"award-number":["SHDC12016116"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Bietti crystalline dystrophy (BCD) is a distinct entity of retinitis pigmentosa with a wide range of genotypic and phenotypic variabilities. The goal of the present study was to investigate the morphological, functional and genetic features of BCD.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A full series of multimodal imaging was performed in four Chinese patients with BCD, including fundus photography, fundus autofluorescence, fundus fluorescein angiography (FFA), indocyanine green (ICG) angiography, optical coherence tomography (OCT) and microperimetry. Electrophysiological tests including full-field electroretinography (ERG) and multifocal ERG were employed. CYP4V2 gene sequencing was performed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Intraretinal crystalline deposits were observed in fundus photographs in all patients. The crystals were better appreciated in infrared images. Autofluorescence imaging demonstrated multifocal patchy hypofluorescence, suggesting massive RPE atrophy. FFA and ICG angiography further confirmed atrophy of the RPE and the underlying choroidal vessels. OCT revealed disruption of the photoreceptors, RPE and the choroid. Outer retinal tubulations (ORTs) confining to the outer nuclear layer were detected in three out of four patients. Full-field ERG showed markedly diminished responses. Multifocal ERG displayed reduced central and peripheral responses in a patient with normal vision. Gene sequencing identified two deletion mutations in CYP4V2, c.802_807del and c.810delT. BCD complicated by choroidal neovascularization (CNV) was diagnosed in one patient, and intravitreal anti-vascular endothelial growth factor (VEGF) injection was given with favorable response.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Multimodal imaging features and electrophysiological findings of BCD patients were comprehensively discussed. A novel deletion mutation, c.802_807del, in the CYP4V2 gene was reported. ORTs are important changes in the outer retina of BCD patients, further investigation of this structure may provide insights into pathology of BCD. Intravitreal anti-VEGF therapy was effective for treatment of BCD complicated by CNV.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12886-020-01545-3","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T09:02:48Z","timestamp":1597482168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Multimodal imaging features and genetic findings in Bietti crystalline dystrophy"],"prefix":"10.1186","volume":"20","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2430-8432","authenticated-orcid":false,"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,15]]},"reference":[{"issue":"3","key":"1545_CR1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00006982-200406000-00013","volume":"24","author":"A Mataftsi","year":"2004","unstructured":"Mataftsi A, Zografos L, Milla E, Secretan M, Munier FL. Bietti's crystalline corneoretinal dystrophy: a cross-sectional study. Retina. 2004;24(3):416\u201326.","journal-title":"Retina"},{"issue":"5","key":"1545_CR2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0002-9394(14)76572-9","volume":"118","author":"MI Kaiser-Kupfer","year":"1994","unstructured":"Kaiser-Kupfer MI, Chan CC, Markello TC, Crawford MA, Caruso RC, Csaky KG, Guo J, Gahl WA. Clinical biochemical and pathologic correlations in Bietti's crystalline dystrophy. Am J Ophthalmol. 1994;118(5):569\u201382.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1545_CR3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/138920211795860071","volume":"12","author":"M Chizzolini","year":"2011","unstructured":"Chizzolini M, Galan A, Milan E, Sebastiani A, Costagliola C, Parmeggiani F. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genomics. 2011;12(4):260\u20136.","journal-title":"Curr Genomics"},{"issue":"5","key":"1545_CR4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/383228","volume":"74","author":"A Li","year":"2004","unstructured":"Li A, Jiao X, Munier FL, Schorderet DF, Yao W, Iwata F, Hayakawa M, Kanai A, Shy Chen M, Alan Lewis R, et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet. 2004;74(5):817\u201326.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1545_CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mgg3.109","volume":"3","author":"GD Astuti","year":"2015","unstructured":"Astuti GD, Sun V, Bauwens M, Zobor D, Leroy BP, Omar A, Jurklies B, Lopez I, Ren H, Yazar V, et al. Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti\u2019s retinal dystrophy. Mol Genet Genomic Med. 2015;3(1):14\u201329.","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"1545_CR6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.112.080085","volume":"82","author":"M Nakano","year":"2012","unstructured":"Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE. CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of omega-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol Pharmacol. 2012;82(4):679\u201386.","journal-title":"Mol Pharmacol"},{"issue":"8","key":"1545_CR7","first-page":"1707","volume":"42","author":"J Lee","year":"2001","unstructured":"Lee J, Jiao X, Hejtmancik JF, Kaiser-Kupfer M, Gahl WA, Markello TC, Guo J, Chader GJ. The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci. 2001;42(8):1707\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1545_CR8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1167\/iovs.09-3665","volume":"51","author":"TY Lai","year":"2010","unstructured":"Lai TY, Chu KO, Chan KP, Ng TK, Yam GH, Lam DS, Pang CP. Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes. Invest Ophthalmol Vis Sci. 2010;51(2):1092\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1545_CR9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.oret.2018.02.012","volume":"2","author":"A Oishi","year":"2018","unstructured":"Oishi A, Oishi M, Miyata M, Hirashima T, Hasegawa T, Numa S, Tsujikawa A. Multimodal imaging for differential diagnosis of Bietti crystalline dystrophy. Ophthalmol Retina. 2018;2(10):1071\u20137.","journal-title":"Ophthalmol Retina"},{"key":"1545_CR10","doi-asserted-by":"crossref","first-page":"739271","DOI":"10.1155\/2014\/739271","volume":"2014","author":"AO Saatci","year":"2014","unstructured":"Saatci AO, Doruk HC, Yaman A, Oner FH. Spectral domain optical coherence tomographic findings of bietti crystalline dystrophy. J Ophthalmol. 2014;2014:739271.","journal-title":"J Ophthalmol"},{"issue":"1","key":"1545_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10633-008-9155-4","volume":"118","author":"MF Marmor","year":"2009","unstructured":"Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. International Society for Clinical Electrophysiology of V: ISCEV standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118(1):69\u201377.","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"1545_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-012-9353-y","volume":"126","author":"M Bach","year":"2013","unstructured":"Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, Meigen T, Viswanathan S. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol. 2013;126(1):1\u20137.","journal-title":"Doc Ophthalmol"},{"issue":"4","key":"1545_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ejhg.2016.184","volume":"25","author":"X Jiao","year":"2017","unstructured":"Jiao X, Li A, Jin ZB, Wang X, Iannaccone A, Traboulsi EI, Gorin MB, Simonelli F, Hejtmancik JF. Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy. Eur J Hum Genet. 2017;25(4):461\u201371.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"1545_CR14","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1136\/jmg.2004.029066","volume":"42","author":"J Lin","year":"2005","unstructured":"Lin J, Nishiguchi KM, Nakamura M, Dryja TP, Berson EL, Miyake Y. Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy. J Med Genet. 2005;42(6):e38.","journal-title":"J Med Genet"},{"issue":"4","key":"1545_CR15","doi-asserted-by":"crossref","first-page":"e94960","DOI":"10.1371\/journal.pone.0094960","volume":"9","author":"H Yin","year":"2014","unstructured":"Yin H, Jin C, Fang X, Miao Q, Zhao Y, Chen Z, Su Z, Ye P, Wang Y, Yin J. Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophy. PLoS One. 2014;9(4):e94960.","journal-title":"PLoS One"},{"issue":"1","key":"1545_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/13816818609058037","volume":"7","author":"M Yuzawa","year":"1986","unstructured":"Yuzawa M, Mae Y, Matsui M. Bietti's crystalline retinopathy. Ophthalmic Paediatr Genet. 1986;7(1):9\u201320.","journal-title":"Ophthalmic Paediatr Genet"},{"issue":"3","key":"1545_CR17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.2010.199356","volume":"96","author":"H Kojima","year":"2012","unstructured":"Kojima H, Otani A, Ogino K, Nakagawa S, Makiyama Y, Kurimoto M, Guo C, Yoshimura N. Outer retinal circular structures in patients with Bietti crystalline retinopathy. Br J Ophthalmol. 2012;96(3):390\u20133.","journal-title":"Br J Ophthalmol"},{"key":"1545_CR18","doi-asserted-by":"crossref","first-page":"283603","DOI":"10.1155\/2014\/283603","volume":"2014","author":"K Gocho","year":"2014","unstructured":"Gocho K, Kameya S, Akeo K, Kikuchi S, Usui A, Yamaki K, Hayashi T, Tsuneoka H, Mizota A, Takahashi H. High-resolution imaging of patients with Bietti crystalline dystrophy with CYP4V2 mutation. J Ophthalmol. 2014;2014:283603.","journal-title":"J Ophthalmol"},{"issue":"6","key":"1545_CR19","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ophtha.2013.11.042","volume":"121","author":"S Halford","year":"2014","unstructured":"Halford S, Liew G, Mackay DS, Sergouniotis PI, Holt R, Broadgate S, Volpi EV, Ocaka L, Robson AG, Holder GE, et al. Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy. Ophthalmology. 2014;121(6):1174\u201384.","journal-title":"Ophthalmology"},{"issue":"3","key":"1545_CR20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/IAE.0b013e3181c96a15","volume":"30","author":"ME Pennesi","year":"2010","unstructured":"Pennesi ME, Weleber RG. High-resolution optical coherence tomography shows new aspects of Bietti crystalline retinopathy. Retina. 2010;30(3):531\u20132.","journal-title":"Retina"},{"issue":"12","key":"1545_CR21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archophthalmol.2009.326","volume":"127","author":"SA Zweifel","year":"2009","unstructured":"Zweifel SA, Engelbert M, Laud K, Margolis R, Spaide RF, Freund KB. Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol. 2009;127(12):1596\u2013602.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1545_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000346854","volume":"229","author":"F Faria-Correia","year":"2013","unstructured":"Faria-Correia F, Barros-Pereira R, Queiros-Mendanha L, Fonseca S, Mendonca L, Falcao MS, Brandao E, Falcao-Reis F, Carneiro AM. Characterization of neovascular age-related macular degeneration patients with outer retinal tubulations. Ophthalmologica. 2013;229(3):147\u201351.","journal-title":"Ophthalmologica"},{"issue":"12","key":"1545_CR23","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2014.06.013","volume":"121","author":"JY Lee","year":"2014","unstructured":"Lee JY, Folgar FA, Maguire MG, Ying GS, Toth CA, Martin DF, Jaffe GJ, Group CR. Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2014;121(12):2423\u201331.","journal-title":"Ophthalmology"},{"issue":"9","key":"1545_CR24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ophtha.2017.03.043","volume":"124","author":"R Dolz-Marco","year":"2017","unstructured":"Dolz-Marco R, Litts KM, Tan ACS, Freund KB, Curcio CA. The evolution of outer retinal tubulation, a neurodegeneration and gliosis prominent in macular diseases. Ophthalmology. 2017;124(9):1353\u201367.","journal-title":"Ophthalmology"},{"issue":"3","key":"1545_CR25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9394(01)00963-1","volume":"132","author":"T Usui","year":"2001","unstructured":"Usui T, Tanimoto N, Takagi M, Hasegawa S, Abe H. Rod and cone a-waves in three cases of Bietti crystalline chorioretinal dystrophy. Am J Ophthalmol. 2001;132(3):395\u2013402.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1545_CR26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/112067210701700434","volume":"17","author":"AM Mansour","year":"2007","unstructured":"Mansour AM, Uwaydat SH, Chan CC. Long-term follow-up in Bietti crystalline dystrophy. Eur J Ophthalmol. 2007;17(4):680\u20132.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"1545_CR27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/13816810.2011.559653","volume":"32","author":"S Rossi","year":"2011","unstructured":"Rossi S, Testa F, Li A, Iorio VD, Zhang J, Gesualdo C, Corte MD, Chan CC, Fielding Hejtmancik J, Simonelli F. An atypical form of Bietti crystalline dystrophy. Ophthalmic Genet. 2011;32(2):118\u201321.","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"1545_CR28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bjophthalmol-2012-302469","volume":"97","author":"S Rossi","year":"2013","unstructured":"Rossi S, Testa F, Li A, Yaylacioglu F, Gesualdo C, Hejtmancik JF, Simonelli F. Clinical and genetic features in Italian Bietti crystalline dystrophy patients. Br J Ophthalmol. 2013;97(2):174\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1545_CR29","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/bjophthalmol-2017-311313","volume":"102","author":"M Miyata","year":"2018","unstructured":"Miyata M, Oishi A, Hasegawa T, Ishihara K, Oishi M, Ogino K, Sugahara M, Hirashima T, Hata M, Yoshikawa M, et al. Choriocapillaris flow deficit in Bietti crystalline dystrophy detected using optical coherence tomography angiography. Br J Ophthalmol. 2018;102(9):1208\u201312.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1545_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4274\/tjo.galenos.2018.90768","volume":"49","author":"SC Ipek","year":"2019","unstructured":"Ipek SC, Ayhan Z, Kadayifcilar S, Saatci AO. Swept-source optical coherence tomography angiography in a patient with Bietti crystalline dystrophy followed for ten years. Turk J Ophthalmol. 2019;49(2):106\u20138.","journal-title":"Turk J Ophthalmol"},{"issue":"10","key":"1545_CR31","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1167\/iovs.17-21515","volume":"58","author":"T Hirashima","year":"2017","unstructured":"Hirashima T, Miyata M, Ishihara K, Hasegawa T, Sugahara M, Ogino K, Yoshikawa M, Hata M, Kuroda Y, Muraoka Y, et al. Choroidal vasculature in Bietti crystalline dystrophy with CYP4V2 mutations and in retinitis Pigmentosa with EYS mutations. Invest Ophthalmol Vis Sci. 2017;58(10):3871\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1545_CR32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/13816810.2015.1126616","volume":"37","author":"NM Fuerst","year":"2016","unstructured":"Fuerst NM, Serrano L, Han G, Morgan JI, Maguire AM, Leroy BP, Kim BJ, Aleman TS. Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization. Ophthalmic Genet. 2016;37(4):445\u201352.","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"1545_CR33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.eye.6702673","volume":"21","author":"LS Atmaca","year":"2007","unstructured":"Atmaca LS, Muftuoglu O, Atmaca-Sonmez P. Peripapillary choroidal neovascularization in Bietti crystalline retinopathy. Eye (Lond). 2007;21(6):839\u201342.","journal-title":"Eye (Lond)"},{"issue":"1","key":"1545_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10792-010-9406-8","volume":"31","author":"B Gupta","year":"2011","unstructured":"Gupta B, Parvizi S, Mohamed MD. Bietti crystalline dystrophy and choroidal neovascularisation. Int Ophthalmol. 2011;31(1):59\u201361.","journal-title":"Int Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01545-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T23:11:18Z","timestamp":1628982678000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01545-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01545-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,15]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the Eye and ENT Hospital of Fudan University, and was performed in adherence to the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of the clinical details and clinical images used in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}